You can buy or sell RDHL and other stocks, options, ETFs, and crypto commission-free!
Redhill Biopharma Ltd. American Depositary Shares, also called Redhill Biopharma, is a specialty biopharmaceutical company primarily focused on the development and commercialization of late clinical-stage, proprietary drugs for the treatment of gastrointestinal diseases. Read More It operates through two segments: Commercial Operations and Research & Development. The Commercial Operations segment covers all areas relating to the commercial sales and operating expenses directly related to that activity and is being performed by the Company's U.S. subsidiary. The Research and Development segment includes all activities related to the research and development of therapeutic candidates and is being performed by the Company. The company was founded by Dror Ben-Asher and Ori Shilo on August 3, 2009 and is headquartered in Tel Aviv, Israel.
Tel Aviv, Tel Aviv
52 Week High
52 Week Low
Research And Development
Seeking AlphaMay 7
RedHill Biopharma Ltd. (RDHL) CEO Dror Ben-Asher on Q1 2019 Results - Earnings Call Transcript
RedHill Biopharma Ltd. (NASDAQ:RDHL) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Alexandra Okmian - Investor Relations Dror Ben-Asher - Chief Executive Officer Micha Ben Chorin - Chief Financial Officer Gilead Raday - Chief Operating Officer Guy Goldberg - Chief Business Officer Conference Call Participants Christopher Marai – Nomura | Instinet Stephen Brozak - WBB Securities, LLC Matthew Kaplan - Ladenburg Thalmann & Co. Inc. Jonas Peciulis - Edison Investment Re...
-$0.35 per share
-$0.03 per share